We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UWMC icon
426
UWM Holdings
UWMC
$672M
– –
-32,544
Closed -$277K
VCYT icon
427
Veracyte
VCYT
$4.45B
– –
-12,032
Closed -$410K
VEEV icon
428
Veeva Systems
VEEV
$33.8B
– –
-4,854
Closed -$1.02M
VLTO icon
429
Veralto
VLTO
$24.3B
– –
-7,814
Closed -$874K
VREX icon
430
Varex Imaging
VREX
$462M
– –
-69,617
Closed -$830K
VTLE
431
DELISTED
Vital Energy
VTLE
– –
-22,667
Closed -$610K
VVX icon
432
V2X
VVX
$2.7B
– –
-4,639
Closed -$259K
WAFD icon
433
WaFd
WAFD
$2.71B
– –
-28,005
Closed -$976K
WBD icon
434
Warner Bros
WBD
$64.3B
– –
-34,113
Closed -$281K
WDFC icon
435
WD-40
WDFC
$2.98B
– –
-3,233
Closed -$834K
WEAV icon
436
Weave Communications
WEAV
$553M
– –
-108,555
Closed -$1.39M
WM icon
437
Waste Management
WM
$95B
– –
-1,958
Closed -$406K
WRB icon
438
W.R. Berkley
WRB
$28.1B
– –
-15,155
Closed -$860K
WSO icon
439
Watsco Inc
WSO
$13.2B
– –
-3,401
Closed -$1.67M
WT icon
440
WisdomTree
WT
$2.79B
– –
-19,462
Closed -$194K
WWD icon
441
Woodward
WWD
$23B
– –
-1,632
Closed -$280K
XEL icon
442
Xcel Energy
XEL
$49.2B
– –
-14,782
Closed -$965K
XPO icon
443
XPO
XPO
$23.4B
– –
-2,386
Closed -$257K
XPOF icon
444
Xponential Fitness
XPOF
$286M
– –
-19,255
Closed -$239K
XRX icon
445
Xerox
XRX
$345M
– –
-34,420
Closed -$357K
YUMC icon
446
Yum China
YUMC
$15.7B
– –
-16,412
Closed -$739K
ZBH icon
447
Zimmer Biomet
ZBH
$18.8B
– –
-7,403
Closed -$799K
ZIMV
448
DELISTED
ZimVie
ZIMV
– –
-38,329
Closed -$608K
ZS icon
449
Zscaler
ZS
$24.9B
– –
-5,600
Closed -$957K
ZTS icon
450
Zoetis
ZTS
$32.7B
– –
-1,683
Closed -$329K
15 16 17
18
19

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.